Feb. 4 at 5:03 PM
$ATOS I have been following this stock closely for over five years. During that time, Iāve both made and lost money on it. After reviewing its history and overall performance, Iāve decided that I would only consider buying again if it drops below
$1, which I believe could happen within the next few weeks or months.
This stock has been heavily shorted and continues to face significant pressure. In my opinion, there may be insiders or competing pharmaceutical companies working against it. While there are currently fewer shares available, the company has not demonstrated meaningful progress or delivered results for shareholders. Instead, it has continued hiring financial advisors and making promises without showing tangible improvements.
I am not a financial advisor, but based on my personal experience, I would advise caution and consider staying away for now. I believe the price may fall below
$1 again soon. Please make sure to do your own due diligence before investing.
